CoChat

Lessons learned: Chronic idiopathic constipation patient experiences with over-the-counter medications

Open access

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Introduction: Chronic idiopathic constipation (CIC) is a prevalent functional gastrointestinal disorder diagnosed based on patient-reported symptoms and the absence of structural gastrointestinal abnormalities. Individuals with CIC typically institute dietary changes and use stool softeners or over-the-counter (OTC) laxatives, possibly at the direction of a healthcare provider, before prescription medications for CIC are initiated. Although highly prevalent, there is limited information regarding CIC patient experiences with OTC medications. Methods: This post-hoc analysis used patient-reported data from a questionnaire administered during patient screening for a prospective linaclotide Phase 3b clinical trial in patients with CIC (N = 1482 screened). The questionnaire asked patients to report their experiences with OTC CIC medications over the preceding 6 months. Results: Among patients with screening responses (N = 1423), most were female (85%) and white (66%), with a mean age of 48.9 years. A high proportion of patients had used one or more OTC medications (70% had ≥1 OTC; 19% had ≥3 OTCs), with the majority being bisacodyl (33%) and polyethylene glycol (30%). The most commonly cited reason for stopping an OTC medication was insufficient symptom relief (17–40%). The majority of patients taking OTC medications reported no or little satisfaction with the medication’s effect on their constipation (62%) and CIC-specific abdominal symptoms (78%). Many patients had little to no confidence in bowel movement (BM) frequency after taking OTC medications and their confidence in their ability to predict BM timing was also low (49–81% not at all confident). Conclusions: Treatment effects on individual CIC symptoms, predictability of bowel habits, and satisfaction with treatment are all important factors for healthcare providers and patients to consider when establishing an effective treatment regimen for CIC. Trial registration number: NCT01642914

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0243318

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Patient satisfaction with OTC medication’s ability to relieve symptoms. Abbreviation: OTC = over-the-counter.
Fig 1 Patient satisfaction with OTC medication’s ability to relieve symptoms. Abbreviation: OTC = over-the-counter.CC BY · PubMed Central
Fig 2 Patient satisfaction with relief of (a) constipation, (b) abdominal bloating, and (c) abdominal discomfort, by treatment. Abbreviation: PEG = polyethylene glycol.
Fig 2 Patient satisfaction with relief of (a) constipation, (b) abdominal bloating, and (c) abdominal discomfort, by treatment. Abbreviation: PEG = polyethylene glycol.CC BY · PubMed Central
Fig 3 Patient confidence in having a bowel movement at least once every other day while taking an OTC medication. Abbreviations: OTC = over-the-counter, PEG = polyethylene glycol.
Fig 3 Patient confidence in having a bowel movement at least once every other day while taking an OTC medication. Abbreviations: OTC = over-the-counter, PEG = polyethylene glycol.CC BY · PubMed Central
Fig 4 Patient confidence in predicting the timing of bowel movements after taking an OTC medication. Abbreviations: OTC = over-the-counter, PEG = polyethylene glycol.
Fig 4 Patient confidence in predicting the timing of bowel movements after taking an OTC medication. Abbreviations: OTC = over-the-counter, PEG = polyethylene glycol.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Research works printed but not linked: 2

  1. JC Eoff, 2008, Optimal treatment of chronic constipation in managed care: review and roundtable discussion, J Manag Care Pharm, 14, 1
  2. DA Drossman, 1999, Rome II: a multinational consensus document on functional gastrointestinal disorders

Cited by

See all 17

Metadata

Authors
Lacy, B. E., Shea, E. P., Manuel, M., Abel, J. L., Jiang, H., & Taylor, D. C. A.
Affiliations
  • Mayo Clinic in Florida (US)
  • Ironwood Pharmaceuticals (United States) (US)
  • AbbVie (United States) (US)
Corresponding author
Lacy, Brian E.
Venue
PLOS ONE
Published
2021-01-11
Volume
16
Issue
1
Pages
e0243318
ISSN
1932-6203 (ISSN-L)
OpenAlex
W3119891294
Cited by
17
References
24
Citations by year
2026: 3 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 1 · 2021: 1
FWCI
2.29
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Allergan plc
  • Ironwood Pharmaceuticals, Inc.
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Urology › Pelvic floor disorders treatments
  • Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
Keywords
chronic idiopathic constipation, over-the-counter laxatives, patient experience, bisacodyl, polyethylene glycol, stool softeners, treatment satisfaction, linaclotide, functional gastrointestinal disorders
MeSH terms
Adolescent, Adult, Aged, Chronic Disease, Constipation, Nonprescription Drugs, Female, Humans, Male, Middle Aged, Peptides, Surveys and Questionnaires, Time Factors, Patient Satisfaction, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lessons learned: Chronic idiopathic constipation patient experiences with over-the-counter medications. https://app.cochat.ai/papers/10.1371/journal.pone.0243318
The paper
Lacy, B. E., Shea, E. P., Manuel, M., Abel, J. L., Jiang, H., & Taylor, D. C. A. (2021). Lessons learned: Chronic idiopathic constipation patient experiences with over-the-counter medications. PLOS ONE. https://doi.org/10.1371/journal.pone.0243318

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.